Omixon at EFI 2023

13/02/2023

We are happy to announce that Omixon will attend the 36th European Immunogenetics & Histocompatibility Conference in Nantes on 26-29 April 2023. The theme of the conference this year will be Big Data in Immunogenetics at The Crossroad of Care, Tools & Research. Visit the Omixon Booth #5 and...

Omixon Biocomputing Ltd is sponsoring PTx Session 6 – Personalized Therapeutics

02/12/2022

We are happy to announce that Omixon Biocomputing Ltd is sponsoring PTx Session 6, Personalized Therapeutics! The Personalized Therapeutics session will be moderated by Amanda Cunningham from UBC, and it takes place on Tuesday, December 13th starting at 11 am.

Omixon Launches NanoTYPE^TM RUO, a Multiplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinION^TM Platform and Enters into an Agreement with Oxford Nanopore Technologies

26/09/2022

High resolution histocompatibility testing for urgent transplant cases made possible within five hours turnaround time. Budapest, Hungary, September 27, 2022. Omixon Biocomputing, Ltd announced today the launch of NanoTYPE^TMRUO, a multiplex 11 loci human leukocyte antigen (HLA) amplification kit and the complementary NanoTYPER^TMsoftware compatible with Oxford Nanopore’s...

BSHI 2022

22/07/2022

BSHI 2022 | British Society for Histocompatibility and Immunogenetics Conference | 13-14 Sept, 2022, London, UK The opportunity to meet us again is open, as Omixon team will be present at the 32nd Annual British Society for Histocompatibility and Immunogenetics Conference in London, UK. Our experts are looking...

ATC 2022

30/05/2022

ATC 2022 | American Transplant Congress | 4-8 June, 2022, Boston MA The opportunity to meet us again is open, as Omixon team will be present at the Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation in Boston, MA, USA. Our...